
tabuk
Winex is an antibiotic containing Cefixime in the form of powder for oral suspension. It provides a concentration of 100 mg per 5 ml after preparation, with a final volume of 60 ml.
Fast shipping
Secure payment
Easy returns
Are you looking for an effective and reliable solution to combat bacterial infections with world-class manufacturing quality? Tabuk Pharmaceuticals presents Winex, an oral suspension specifically designed to provide the necessary treatment with an advanced formula based on Cefixime. Winex is an ideal choice for doctors and patients due to its high efficiency in eliminating infection-causing bacteria, ensuring a fast and safe recovery journey under precise medical supervision.
Winex possesses a range of characteristics that make it a leading choice in its category, including:
The Winex packaging is designed with professional colors including white, yellow, blue, and light gray, with clear data to ensure correct use:
For best results and to ensure the medication's effectiveness, preparation steps must be followed precisely. Add distilled or previously boiled water (after cooling) up to the red line shown on the label, then shake well. Afterward, readjust the volume by adding water up to the line if necessary. Shake the bottle well before each use to ensure even distribution of the active ingredient.
Tabuk Pharmaceutical Manufacturing Company is a symbol of trust in the healthcare sector, dedicated to providing effective medications that meet patient needs and support the healthcare system. With Winex, you are choosing a product that has undergone the highest levels of control and quality to ensure your safety and the safety of your family.
Do not compromise on choosing the most suitable antibiotic for your health condition. Consult your doctor and ask for Winex 100 mg from the pharmacy, and follow the instructions in the internal leaflet carefully. Your health is our priority, and Winex is your trusted partner in fighting infection.
Please sign in to write a review
Please sign in to ask a question